COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING CARNITINE, FOR TREATING AND ACTIVELY PREVENTING DRY SKIN AND OTHER NEGATIVE ALTERATIONS IN THE PHYSIOLOGICAL HOMEOSTASIS OF HEALTHY SKIN

• Main Authors: DOERING, THOMAS, SAUERMANN, GERHARD, SIEFKEN, WILFRIED, CARSTENSEN, STEFANIE, SCHREINER, VOLKER, GATERMANN, CORNELIA, BIERGIESSER, HELGA
• Format: Patent
• Language: English; French; German
• Published: 14.04.2004
• Edition: 7
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS

Use of topical compositions containing carnitine and its precursors, derivatives or metabolites to, e.g. improve skin condition or to treat or prevent skin disorders, abnormal lipid peroxidation, reduced cell-cell communication, deficient intracellular DNA synthesis, DNA damage, deficient DNA repair, abnormal post-translational modification of connective tissue components or dandruff. Topical compositions comprising carnitine and its precursors, derivatives or metabolites and optionally electrolytes, polyols, urea and osmolytes are used: (1) to treat or prevent dry skin, to enhance the barrier function of the skin, for treatment, care and prophylaxis of sensitive skin and/or for treatment and prophylaxis of symptoms of a negative change in the physiological homeostasis of normal skin; (2) to treat or prevent inflammatory skin conditions, atopic eczema, polymorphic photodermatitis, psoriasis, vitiligo and sensitive, itching or irritated skin; (3) to treat or prevent abnormal lipid peroxidation; (4) to treat or prevent abnormal ceramide, lipid and energy metabolism of the skin, abnormal transepidermal water loss, reduced skin hydration and moisture content and altered Natural Moisturizing Factor content; (5) to treat or prevent reduced cell-cell communication, deficient intracellular DNA synthesis, DNA damage, reduced endogenous DNA repair, activation of metalloproteinases and/or other proteases or inhibition of corresponding DNA repair mechanisms and abnormal post-translational modification of connective tissue components; (6) to treat or prevent abnormal skin hyaluronic acid and glucosaminoglycan content; or (7) to treat or prevent dandruff of the hair and scalp and skin aging.